Short answer · Medically reviewed summary · Last updated: 2026-05-08
Sly syndrome, also known as Mucopolysaccharidosis type VII (MPS VII), is an ultra-rare lysosomal storage disorder with an estimated global prevalence of less than 1 in 250,000 births. Due to significant underdiagnosis and the phenotypic variability of the condition, exact epidemiological figures remain difficult to determine, though it is recognized as one of the rarest forms of mucopolysaccharidosis. How common is Sly syndrome? Sly syndrome is classified as an ultra-rare disease.
What is the prevalence of Sly Syndrome?
Prevalence of Sly Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
Sly syndrome, also known as Mucopolysaccharidosis type VII (MPS VII), is an ultra-rare lysosomal storage disorder with an estimated global prevalence of less than 1 in 250,000 births. Due to significant underdiagnosis and the phenotypic variability of the condition, exact epidemiological figures remain difficult to determine, though it is recognized as one of the rarest forms of mucopolysaccharidosis.
How common is Sly syndrome?
Sly syndrome is classified as an ultra-rare disease. Because it is a multisystemic disorder, many cases are likely misdiagnosed as other, more common types of mucopolysaccharidosis or other developmental conditions. While literature often cites a birth prevalence of less than 1 in 250,000, real-world clinical data suggests the true frequency may be higher, though still extremely low. Within the DiseaseMaps.org community, we observe that patients with Sly syndrome often face a long "diagnostic odyssey" before receiving the correct molecular confirmation, which contributes to the difficulty in tracking accurate global prevalence numbers.
What are the demographic patterns of Sly syndrome?
Sly syndrome affects males and females with equal frequency, as it follows an autosomal recessive inheritance pattern. The age of onset varies significantly based on the severity of the GUSB gene mutation:
- Severe/Neonatal: Often presents at birth or in early infancy with hydrops fetalis.
- Attenuated/Late-onset: May present in childhood or adolescence with skeletal abnormalities, hepatosplenomegaly, and cognitive delays.
Why is accurate data for Sly syndrome limited?
Determining the precise number of people living with Sly syndrome is challenging due to several factors:
- Phenotypic Heterogeneity: The wide spectrum of symptoms leads to misdiagnosis or delayed diagnosis.
- Under-reporting: Many cases, particularly those that are fatal in utero or in the neonatal period, may not be captured in standard registries.
- Geographic Variance: While no specific ethnic "hotspots" are definitively established, the rarity of the condition makes it difficult to establish statistically significant regional data.
Next steps
- Consult a metabolic geneticist to confirm a diagnosis via GUSB enzyme assay or molecular genetic testing.
- Connect with the DiseaseMaps.org community to share experiences and find support from families living with Sly syndrome.
- Register with international patient advocacy groups like the National MPS Society to stay informed on emerging clinical trials and research.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult with a qualified healthcare professional regarding your specific health condition.
References
- Orphanet (ORPHA:582) – Mucopolysaccharidosis type VII.
- NIH GARD (Genetic and Rare Diseases Information Center) – Sly syndrome overview.
- OMIM (Online Mendelian Inheritance in Man) – Entry #253220: Mucopolysaccharidosis VII.
- National MPS Society – Clinical resources and patient registry data.
